Go to main content

PDF

Description

Discusses his leading role in Eli Lilly's sponsorship of research on recombinant human insulin, the first genetically engineered pharmaceutical product. Details the contentious race at University of California San Francisco and at Genentech to clone and express the gene for human insulin.

Details

Files

Statistics

from
to
Export
Download Full History
Formats
Format
BibTeX
MARCXML
TextMARC
MARC
DublinCore
EndNote
NLM
RefWorks
RIS